SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-028713
Filing Date
2024-12-05
Accepted
2024-12-05 16:22:21
Documents
1
Period of Report
2024-12-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 6367
  Complete submission text file 0001127602-24-028713.txt   7820
Mailing Address 350 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 350 OYSTER POINT BOULEVARD . SOUTH SAN FRANCISCO CA 94080 (650) 624-3000
CYTOKINETICS INC (Issuer) CIK: 0001061983 (see all company filings)

IRS No.: 943291317 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CYTOKINETICS, INCORPORATED 280 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
Callos Andrew (Reporting) CIK: 0001852129 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50633 | Film No.: 241529387